Genenta Science S.P.A. (GNTA)
Genenta Science S.p.A., a clinical-stage biotechnology company, develops hematopoietic stem cell gene therapies for the treatment of solid tumors in Italy. The...
- Open
- 1.270
- High
- 1.340
- Low
- 1.270
- Prev. Close
- 1.300
- Volume
- 37.96K
- Turnover
- 49.41K
- Avg Price
- 1.301
- Bid/Ask Ratio
- --
- Amplitude
- 5.38%
- 52wk High
- 10.000
- Volume Ratio
- 0.56
- Turnover Ratio
- 0.28%
Genenta Science S.P.A. Analyst Rating
View moreForecast & Rating
Dec 22, 2025Price forecast
$6.97436.24%
Forecast & RatingBuy
1analysts
- Strong buy0.00%
- Buy100.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- PUBT · Jul 31 at 03:06 PM
Genenta Science announces extraordinary shareholders meeting reconvened for Sept. 10-11
- StockTitan · Jul 22 at 06:09 PM
Genenta-backed Sòphia High Tech Brings Aerospace Precision Inside a Nuclear Fusion Reactor with ROMAN, a Robotic Arm | GNTA Stock News
- StockTitan · Jul 21 at 07:00 PM
Genenta-Backed Sòphia High Tech Reports Fiscal Year 2025 Results | GNTA Stock News
- benzinga_article · Jul 20 at 07:05 AM
12 Health Care Stocks Moving In Monday's Pre-Market Session
- PUBT · Jul 14 at 03:07 PM
Milan court lifts suspension of Genenta corporate purpose amendment in shareholder suit
- PUBT · Jul 1 at 03:10 PM
Genenta delays extraordinary shareholder meeting to July 29-30
